Archive for the ‘infectious disease’ Category
The agency’s director, David Wright, stepped down late last month for reasons that even now remain unclear. And in what seems to be an unrelated development, ORI has managed to draw the ire of Sen. Charles Grassley, who has been among the staunchest watchdogs over federal research integrity.
According to the Des Moines Register, the Iowa Republican
AAPS PharmSciTech, a journal of the American Association of Pharmaceutical Scientists, has retracted a 2013 paper by a group from India. The reason appears to be manipulated data, although the wording of the notice leaves that open to interpretation.
The article, “Design and Formulation Technique of a Novel Drug Delivery System for Azithromycin and Its Anti-Bacterial Activity Against Staphylococcus aureus,” was written by a trio of researchers at the Center for Nanobiotechnology at VIT University in Vellore.
In December, we reported on the case of Dong-Pyou Han, who was found by the Office of Research Integrity to have spiked rabbit blood samples to make it look as though a vaccine for HIV was working.
At the time, Han’s former institution, Iowa State, told us that “one oral presentation and some abstracts will be removed from the web.”
The paper, “Avian Reovirus Nonstructural Protein p17-Induced G2/M Cell Cycle Arrest and Host Cellular Protein Translation Shutoff Involve Activation of p53-Dependent Pathways,” came from a group at National Pingtung University of Science and Technology, in Pingtung, China. It purported to find that: Read the rest of this entry »
That must have been what happened to a quintet of authors from Shanghai who’ve just had to retract an article from the Journal of Antimicrobial Chemotherapy. Here’s the notice
(sadly, behind a paywall) [see note at end of post] for “Role of clofazimine in the treatment of multidrug-resistant tuberculosis: a retrospective observational cohort assessment:” Read the rest of this entry »
A group of researchers in China has lost a paper on the human microbiome in Frontiers in Cellular and Infection Microbiology for cannibalizing much of it from previously published work by other scientists.
The article, titled “Human gut microbiota: dysbiosis and manipulation,” appeared on Sept. 27, 2012, and was written by a team from the Beijing Genomics Institute-Shenzhen. It has been cited just once, according to Thomson Scientific’s Web of Knowledge, by another paper in the same journal.
A group of virologists from Kazakhstan and Russia have lost their 2011 bird flu article in Virologica Sinica. Their offense: plagiarizing from a previous article by a team from Sweden on a similar topic.
The paper, “Phylogenetic Analysis of the Non-structural (NS) Gene of Influenza A Viruses Isolated in Kazakhstan in 2002–2009,” which purported to show that: Read the rest of this entry »